Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Findings from three methods to identify falls in hospitals: Results from the Ambient Intelligent Geriatric Management system fall prevention trial.

Australasian journal on ageing·2023

Same author

Corrigendum to "The clinical profile of people with knee osteoarthritis and a self-reported prior knee injury: A cross-sectional study of 10,973 peopleˮ [Osteoarthritis Cartilage 29 (2021) 341-345].

Osteoarthritis and cartilage·2021

Same author

The clinical profile of people with knee osteoarthritis and a self-reported prior knee injury: A cross-sectional study of 10,973 people.

Osteoarthritis and cartilage·2021

Same author

Dataset for the reporting of carcinoma of the bladder-cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Virchows Archiv : an international journal of pathology·2020

Same author

Five-year follow-up of patients treated with intra-dermal botulinum toxin for axillary hyperhidrosis.

Irish journal of medical science·2020

Same author

Dataset for the reporting of urinary tract carcinoma-biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2019

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

P-glycoprotein expression in non-hodgkins-lymphoma.

R West¹, E Boyle, D Grignon

¹VICTORIA HOSP,DEPT HEMATOL,375 SOUTH ST,LONDON N6A 4G5,ONTARIO,CANADA. UNIV WESTERN ONTARIO,DEPT BIOSTATIST & EPIDEMIOL,LONDON N6A 4G5,ON,CANADA. VICTORIA HOSP,DEPT PATHOL,LONDON N6A 4G5,ONTARIO,CANADA. HARPER GRACE HOSP,DEPT PATHOL,DETROIT,MI 48201.

International Journal of Oncology

|May 14, 2011

Summary

P-glycoprotein (Pgp), linked to multidrug resistance, was found in 21% of non-Hodgkin's lymphoma (NHL) patients. Pgp expression did not correlate with patient factors or treatment response in this study.

More Related Videos

Preparation of CD4+ T Cells for Analysis of GD3 and GD2 Ganglioside Membrane Expression by Microscopy

Preparation of CD4⁺ T Cells for Analysis of GD3 and GD2 Ganglioside Membrane Expression by Microscopy

Published on: November 8, 2016

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

Related Experiment Videos

Last Updated: Jun 2, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

Preparation of CD4+ T Cells for Analysis of GD3 and GD2 Ganglioside Membrane Expression by Microscopy

Preparation of CD4⁺ T Cells for Analysis of GD3 and GD2 Ganglioside Membrane Expression by Microscopy

Published on: November 8, 2016

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

Area of Science:

Oncology
Molecular Biology
Biochemistry

Background:

Non-Hodgkin's lymphoma (NHL) is a heterogeneous group of lymphoid malignancies.
Multidrug resistance (MDR) is a significant challenge in NHL treatment.
P-glycoprotein (Pgp) is a key transmembrane protein implicated in MDR.

Purpose of the Study:

To investigate the expression of P-glycoprotein (Pgp) in non-Hodgkin's lymphoma (NHL) tissues.
To determine the correlation between Pgp expression and clinicopathological factors in NHL patients.
To assess the association between Pgp expression and treatment response in NHL.

Main Methods:

Immunohistochemical analysis of Pgp expression in NHL tissue samples.
Correlation analysis with patient age, disease stage, lactate dehydrogenase levels, extranodal involvement, and prior chemotherapy.
Comparison of Pgp expression in complete responders versus partial or non-responders.

Main Results:

Pgp was expressed in 6 out of 29 (21%) NHL patients.
Pgp expression was observed in 38% of low-grade and 19% of intermediate-grade NHL.
No significant association was found between Pgp expression and age, stage, LDH, extranodal disease, prior chemotherapy, or treatment response (p>0.10).

Conclusions:

P-glycoprotein (Pgp) expression is present in a subset of non-Hodgkin's lymphoma (NHL) cases.
Pgp expression in NHL does not appear to be directly associated with common clinical parameters or treatment outcomes in this cohort.
Further research may be warranted to elucidate the role of Pgp in NHL pathogenesis and resistance mechanisms.